Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Institute of Kidney Lifescience |
Description | SGLT2 Home Archived Resources About IKLT More than 1.9 million Canadians have Chronic Kidney Disease. We hope to reduce the burden of disease by early identific |
Keywords | N/A |
WebSite | kidneylifescience.ca |
Host IP | 155.138.142.35 |
Location | United States |
Site | Rank |
US$256,444
Last updated: 2022-06-13 11:17:06
kidneylifescience.ca has Semrush global rank of 41,273,431. kidneylifescience.ca has an estimated worth of US$ 256,444, based on its estimated Ads revenue. kidneylifescience.ca receives approximately 29,590 unique visitors each day. Its web server is located in United States, with IP address 155.138.142.35. According to SiteAdvisor, kidneylifescience.ca is safe to visit. |
Purchase/Sale Value | US$256,444 |
Daily Ads Revenue | US$237 |
Monthly Ads Revenue | US$7,102 |
Yearly Ads Revenue | US$85,219 |
Daily Unique Visitors | 1,973 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
kidneylifescience.ca. | A | 600 | IP: 155.138.142.35 |
kidneylifescience.ca. | NS | 3600 | NS Record: ns14.domaincontrol.com. |
kidneylifescience.ca. | NS | 3600 | NS Record: ns13.domaincontrol.com. |
Home Archived Resources About IKLT More than 1.9 million Canadians have Chronic Kidney Disease. We hope to reduce the burden of disease by early identification and prevention through education. RECORDINGS RESOURCES FAQ --> SGLT2 Inhibitors SGLT2 inhibition has been shown to provide cardioprotective and renal protective effects. In this talk, Dr. Robert Ting presents recent clinical data on SGLT2i and reviews their place in the management of Canadians patients with chronic kidney disease (CKD), with or without type 2 diabetes (T2D). SGLT2 inhibitors Presentation --> Proteinuria Primer Albuminuria is associated with a higher risk of progressive renal disease leading to dialysis, and more importantly, a greater risk of cardiovascular (CV) outcomes. This presentation by Dr. Sheldon Tobe examines the impact of proteinuria and its treatment on clinical outcomes. Novel approaches discussed included the use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and non-steroidal |
HTTP/1.1 301 Moved Permanently Server: nginx Date: Wed, 20 Oct 2021 17:42:04 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://kidneylifescience.ca/ HTTP/2 200 server: nginx date: Wed, 20 Oct 2021 17:42:05 GMT content-type: text/html; charset=utf-8 content-length: 40444 vary: Accept-Encoding cache-provider: CLOUDWAYS-CACHE-DE last-modified: Wed, 20 Oct 2021 12:37:32 GMT vary: Accept-Encoding age: 3816 x-cache: HIT accept-ranges: bytes |
Domain Name: kidneylifescience.ca Registry Domain ID: D356364-CIRA Registrar WHOIS Server: whois.ca.fury.ca Registrar URL: ca.godaddy.com Updated Date: 2021-03-24T05:05:28Z Creation Date: 2006-02-07T20:25:50Z Registry Expiry Date: 2022-02-07T05:00:00Z Registrar: Go Daddy Domains Canada, Inc Registrar IANA ID: not applicable Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ns13.domaincontrol.com Name Server: ns14.domaincontrol.com DNSSEC: unsigned >>> Last update of WHOIS database: 2021-09-09T07:32:01Z <<< |